| Q46249993 | A Novel Pkhd1 Mutation Interacts with the Nonobese Diabetic Genetic Background To Cause Autoimmune Cholangitis |
| Q57908850 | A mouse model for cystic biliary dysgenesis in autosomal recessive polycystic kidney disease (ARPKD) |
| Q51752480 | A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation. |
| Q26800974 | A polycystin-centric view of cyst formation and disease: the polycystins revisited |
| Q26824716 | ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies |
| Q34568735 | Aberrant glycosylation and localization of polycystin-1 cause polycystic kidney in an AQP11 knockout model |
| Q33987179 | Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD. |
| Q28578050 | Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease |
| Q37345965 | Advances in management of polycystic liver disease |
| Q34393436 | Algorithm for efficient PKHD1 mutation screening in autosomal recessive polycystic kidney disease (ARPKD). |
| Q34465976 | An incredible decade for the primary cilium: a look at a once-forgotten organelle |
| Q39436033 | Animal models of biliary injury and altered bile acid metabolism |
| Q36559697 | Biliary and pancreatic dysgenesis in mice harboring a mutation in Pkhd1. |
| Q35103361 | Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease |
| Q37798910 | Calcium-mediated mechanisms of cystic expansion |
| Q38345944 | Caroli's Disease: Current Knowledge of Its Biliary Pathogenesis Obtained from an Orthologous Rat Model |
| Q37415464 | Centrosomal abnormalities characterize human and rodent cystic cholangiocytes and are associated with Cdc25A overexpression. |
| Q36506477 | Cholangiocyte anion exchange and biliary bicarbonate excretion |
| Q28579739 | Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling |
| Q36277264 | Cholangiocyte cilia express TRPV4 and detect changes in luminal tonicity inducing bicarbonate secretion. |
| Q28577465 | Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors |
| Q36953076 | Cholangiocyte primary cilia in liver health and disease |
| Q36202846 | Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat |
| Q24337720 | Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3 |
| Q37175323 | Ciliary dysfunction in polycystic kidney disease: an emerging model with polarizing potential |
| Q37008383 | Congenital cholestatic syndromes: what happens when children grow up? |
| Q35655072 | Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease |
| Q35086473 | Deciphering physiological role of the mechanosensitive TRPV4 channel in the distal nephron |
| Q40265981 | Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of Autosomal Recessive Polycystic Kidney Disease |
| Q36505469 | Diagnosis, pathogenesis, and treatment prospects in cystic kidney disease |
| Q46584628 | Diffuse expression of heparan sulfate proteoglycan and connective tissue growth factor in fibrous septa with many mast cells relate to unresolving hepatic fibrosis of congenital hepatic fibrosis |
| Q34846108 | Disease Stage Characterization of Hepatorenal Fibrocystic Pathology in the PCK Rat Model of ARPKD |
| Q39364606 | Disease modeling in genetic kidney diseases: mice. |
| Q82488439 | Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease |
| Q28594258 | Fibrocystin/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function |
| Q35856772 | Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia. |
| Q36812610 | Flagellar length control in chlamydomonas--paradigm for organelle size regulation |
| Q33564793 | Flagellar length control system: testing a simple model based on intraflagellar transport and turnover |
| Q42594856 | Functional analysis of PKHD1 splicing in autosomal recessive polycystic kidney disease |
| Q34779022 | Functional anatomy of normal bile ducts |
| Q36357916 | Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity |
| Q50301021 | Genetics of Autosomal Recessive Polycystic Kidney Disease and Its Differential Diagnoses |
| Q28572123 | HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis |
| Q33866793 | Heterogeneity of the intrahepatic biliary epithelium |
| Q24338175 | Inhibition of PKHD1 may cause S-phase entry via mTOR signaling pathway |
| Q28586052 | Inhibition of Pkhd1 impairs tubulomorphogenesis of cultured IMCD cells |
| Q41091349 | Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib |
| Q42269057 | Initial evaluation of hepatic T1 relaxation time as an imaging marker of liver disease associated with autosomal recessive polycystic kidney disease (ARPKD). |
| Q36679348 | Molecular and cellular pathogenesis of autosomal recessive polycystic kidney disease. |
| Q36787582 | Molecular mechanism of liver development and regeneration |
| Q36559639 | Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease |
| Q41353750 | NEDD4-family E3 ligase dysfunction due to PKHD1/Pkhd1 defects suggests a mechanistic model for ARPKD pathobiology. |
| Q33997942 | Novel Mutation in the PKHD1 Gene Diagnosed Prenatally in a Fetus with Autosomal Recessive Polycystic Kidney Disease |
| Q35755781 | PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD). |
| Q24311878 | PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells |
| Q92959992 | Pancreatic Ductal Deletion of Hnf1b Disrupts Exocrine Homeostasis, Leads to Pancreatitis, and Facilitates Tumorigenesis |
| Q92532305 | Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases |
| Q34860483 | Patients, cells, and organelles: the intersection of science and serendipity |
| Q27008523 | Physiology of cholangiocytes |
| Q30435066 | Pkd1 transgenic mice: adult model of polycystic kidney disease with extrarenal and renal phenotypes |
| Q28283470 | Polycystic disease of the liver |
| Q35660081 | Polycystic diseases in visceral organs |
| Q33709685 | Polycystic kidney disease |
| Q24322601 | Polycystic kidney disease protein fibrocystin localizes to the mitotic spindle and regulates spindle bipolarity |
| Q83182810 | Polycystic liver disease: new insights into disease pathogenesis |
| Q33949172 | Polycystic liver diseases. |
| Q27001174 | Polycystic liver diseases: advanced insights into the molecular mechanisms |
| Q30479973 | Polyductin undergoes notch-like processing and regulated release from primary cilia |
| Q24305942 | Polyductin, the PKHD1 gene product, comprises isoforms expressed in plasma membrane, primary cilium, and cytoplasm |
| Q95822241 | Proceedings of the 21st International Bile Acid Meeting. October 7-14, 2010, Freiburg, Germany |
| Q34774643 | Progress and prospects in rat genetics: a community view. |
| Q53600876 | Proteolytic cleavage and nuclear translocation of fibrocystin is regulated by intracellular Ca2+ and activation of protein kinase C. |
| Q47737330 | Recent advances in the molecular diagnosis of polycystic kidney disease |
| Q36703547 | Role of renal TRP channels in physiology and pathology |
| Q54275100 | Roles of myofibroblasts and notch and hedgehog signaling pathways in the formation of intrahepatic bile duct lesions in polycystic kidney rats. |
| Q85887537 | Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan |
| Q33809680 | Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney disease |
| Q38764445 | TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling |
| Q40867711 | TGR5 in the Cholangiociliopathies |
| Q43044442 | Tagged fibrocystin sheds its secrets. |
| Q34717186 | The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD). |
| Q39381392 | The cholangiocyte primary cilium in health and disease. |
| Q37796679 | The primary cilium in different tissues-lessons from patients and animal models |
| Q35082225 | The role of cilia in the regulation of bile flow |
| Q38443908 | Therapeutic Targets in Polycystic Liver Disease |
| Q99591839 | Type IV choledochal cyst with polycystic kidney disease: a case report |
| Q29547198 | When cilia go bad: cilia defects and ciliopathies |
| Q81493675 | [Cystic liver diseases. Genetics and cell biology] |